Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1194679018 | Tauroselcholic acid[75Se] 37kBq capsule (product) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3471674015 | Tauroselcholic acid[75Se] 37 kBq/1 each oral capsule | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3471675019 | Product containing tauroselcholic acid[75Se] 37 kBq/1 each oral capsule | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3485060014 | Product containing tauroselcholic acid[75Se] 37 kBq/1 each oral capsule (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3567505013 | Product containing only tauroselcholic acid[75Se] 37 kBq/1 each oral capsule (clinical drug) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3567506014 | Product containing only tauroselcholic acid[75Se] 37 kBq/1 each oral capsule | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3683280014 | Product containing precisely tauroselcholic acid (75-Se) 37 kilobecquerel/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3683281013 | Product containing precisely tauroselcholic acid (75-Se) 37 kilobecquerel/1 each conventional release oral capsule | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3683282018 | Tauroselcholic acid (75-Se) 37 kBq oral capsule | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 472575018 | Tauroselcholic acid[75Se] 37kBq capsule | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 726906016 | Tauroselcholic acid[75Se] 37kBq capsule (substance) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely tauroselcholic acid (75-Se) 37 kilobecquerel/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | Product containing only selenium-75 in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely tauroselcholic acid (75-Se) 37 kilobecquerel/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | Product containing selenium-75 (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely tauroselcholic acid (75-Se) 37 kilobecquerel/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Tauroselcholic acid (75-Se) (substance) | false | Inferred relationship | Some | ||
| Product containing precisely tauroselcholic acid (75-Se) 37 kilobecquerel/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Selenium radioisotope | false | Inferred relationship | Some | ||
| Product containing precisely tauroselcholic acid (75-Se) 37 kilobecquerel/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | Capsule | false | Inferred relationship | Some | ||
| Product containing precisely tauroselcholic acid (75-Se) 37 kilobecquerel/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Selenium-75 (substance) | false | Inferred relationship | Some | ||
| Product containing precisely tauroselcholic acid (75-Se) 37 kilobecquerel/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | Oral capsule | true | Inferred relationship | Some | ||
| Product containing precisely tauroselcholic acid (75-Se) 37 kilobecquerel/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely tauroselcholic acid (75-Se) 37 kilobecquerel/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Tauroselcholic acid (75-Se) (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely tauroselcholic acid (75-Se) 37 kilobecquerel/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Tauroselcholic acid (75-Se) (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely tauroselcholic acid (75-Se) 37 kilobecquerel/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value (attribute) | 37 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely tauroselcholic acid (75-Se) 37 kilobecquerel/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | Kilobecquerel (qualifier value) | true | Inferred relationship | Some | 1 | |
| Product containing precisely tauroselcholic acid (75-Se) 37 kilobecquerel/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Product containing precisely tauroselcholic acid (75-Se) 37 kilobecquerel/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely tauroselcholic acid (75-Se) 37 kilobecquerel/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | Capsule (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely tauroselcholic acid (75-Se) 37 kilobecquerel/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Tauroselcholic acid (75-Se) (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely tauroselcholic acid (75-Se) 37 kilobecquerel/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | Product containing selenium-75 in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely tauroselcholic acid (75-Se) 37 kilobecquerel/1 each conventional release oral capsule (clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR